Dow Inc. offers asymmetric cyclical recovery upside through North American feedstock advantages and aggressive self-help, but leverage, litigation, and weak near-term guidance keep execution risk high.
Overview
Dow is a global materials science company whose integrated chemical hubs convert hydrocarbon feedstocks into polyethylene, polyurethane systems, silicones, coatings, and industrial intermediates for diversified B2B customers in approximately 160 countries. Its competitive position rests on world-scale assets, North American ethane feedstock economics, supply reliability, and technically qualified products that create customer switching costs. **Q2 2026 showed a sharp operational inflection:** sales rose 20% year over year to $12.092 billion, GAAP net income swung to $802 million from a $801 million loss, operating EBITDA increased to $2.312 billion from $703 million, and operating EPS of $1.44 exceeded the $1.25-$1.29 consensus range by 15.2%. Management also raised 2026 self-help expectations to more than $1.3 billion, including $700 million of in-year savings. The near-term setup is mixed because Q3 operating EBITDA is guided to approximately $1.7 billion, reflecting flat pricing, turnarounds, and the absence of a $50 million Taiwan land-sale gain. At $31.18, valuation offers substantial modeled upside, but the stock remains exposed to commodity cyclicality, leverage, legal liabilities, and execution risk. The report’s 55% base case implies $74.84 in five years, while the probability-weighted target is $75.74.